Hepatitis C virus vaccines--progress and perspectives.

@article{Fauvelle2013HepatitisCV,
  title={Hepatitis C virus vaccines--progress and perspectives.},
  author={Catherine Fauvelle and Quentin Lepiller and Daniel Jeffery Felmlee and Isabel Fofana and François Habersetzer and Françoise Stoll-Keller and Thomas F Baumert and Samira Fafi-Kremer},
  journal={Microbial pathogenesis},
  year={2013},
  volume={58},
  pages={
          66-72
        }
}
Approximately 170 million individuals, representing 3% of the global population, are infected with hepatitis C virus (HCV). Whereas strategies for antiviral therapies have markedly improved resulting in clinical licensing of direct-acting antivirals, the development of vaccines has been hampered by the high genetic variability of the virus as well as by the lack of suitable animal models for proof-of-concept studies. Nevertheless, there are several promising vaccine candidates in preclinical… CONTINUE READING
Highly Cited
This paper has 23 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations